Translational Research in Malignancy Members
The Translational Research in Malignancy (TRIM) program is a highly interactive translational cancer research program. Its main objective is to conduct studies centered on molecular mechanisms of cancer progression and therapeutic resistance and to translate basic science and preclinical discoveries into early diagnosis, biomarkers, and cancer therapeutics.
Dmello, Crismita
Research Assistant Professor
Bio
My central hypothesis is that glioma cell-specific Chek2-YBX1/3 interaction transcriptionally reprograms the glioma cells to escape the CD8 T cell mediated killing.
Donnelly, Eric
Associate Professor
Bio
My interests have focused on the treatment of gynecologic malignancies, breast cancer and lymphomas, in particular the treatment, toxicity, and follow-up to improve long term outcomes and overall qual... [more]
Eckerdt, Frank
Research Associate Professor
Bio
The goal of my research is to define and target signaling networks promoting resistance mechanisms in cancer stem cells (CSCs) of the brain. Brain cancers are heterogeneous tumors, exhibitin... [more]
Eklund, Elizabeth A.
Professor
Bio
The focus of my laboratory is to understand the key events in normal myelopoiesis and how leukemia-associated mutations derange these processes during leukemogenesis.
Fenton, Sarah
Assistant Professor
Bio
Dr. Sarah Fenton has a clinical focus on the management of genitourinary cancers including prostate, bladder, kidney and testicular cancer. Her research focuses on the identification of novel therapeu... [more]
Gao, Juehua
Associate Professor
Bio
My research focus is on molecular biomarkers that provide diagnostic and prognostic value in leukemia and lymphoma. I am also interested in the development of sensitive and accurate molecular tests to... [more]
Gerami, Pedram
Professor
Bio
My research lab has extensive experience in performing fluorescence in situ hybridization on formalin fixed paraffin embedded specimens as well as mutational analysis. As a result of some of our recen... [more]
Godley, Lucy
Professor
Bio
The Godley laboratory studies the molecular pathways that drive hematopoietic malignancies, with a focus on understanding how germline predisposition alleles contribute to individual and family risk a... [more]
Gordon, Leo I.
Professor
Bio
Novel signaling pathways in lymphoma, using cell lines and animal model systems. More specifically, our research focuses on the biology of reactive oxygen species signaling pathways in lymphoma. Activ... [more]
Gradishar, William J.
Professor
Bio
My research focuses on the development of novel therapeutics for the treatment of breast cancer.